Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 30, 2024 8:36 AM 2 min read

Temasek Pours $30B Into US Amid Booming Economic Growth

by Benzinga Neuro Benzinga Staff Writer
Follow

In a recent move, Singapore’s state investor, Temasek, has declared its intention to pump as much as $30 billion into the U.S. market over the next five years.

What Happened: Temasek’s investment strategy will primarily target sectors such as healthcare, financial services, and technology, Reuters reported on Tuesday. The U.S.’s leading position in the field of artificial intelligence (AI) has been a significant influence on this decision, according to Jane Atherton, Temasek’s head of North America.

Despite recent market volatility, the U.S. economy has demonstrated strong growth, outperforming its global counterparts. The S&P 500 has recorded a 14.5% rise this year, partly fueled by the buzz around the AI sector.

Last financial year, Temasek’s investment in the Americas, currently standing at 22% or $63 billion, exceeded its China exposure for the first time in ten years. The firm has shown particular interest in AI-related sectors in the U.S., such as data centers, semiconductors, and battery storage.

See Also: Nasdaq, S&P 500 To Start New Week In The Green: What’s Driving Sentiment

Atherton indicated that future U.S. stock performance would be largely earnings-dependent, especially in the tech megacap sector. Temasek is also considering investments in both public and private markets as more private equity firms plan to divest.

Earlier this month, Temasek revealed that profits from U.S. and India investments were counterbalancing underperformance in China. The firm is adopting a cautious stance towards China due to persistent trade tensions.

Why It Matters: Temasek’s decision to invest heavily in the U.S. comes at a time when the American economy is showing remarkable resilience, outpacing expectations with a surprising real GDP growth of 2.8% in the second quarter. This performance has led some experts to suggest that if economic performance were an Olympic sport, the U.S. economy would take home the gold.

Furthermore, the U.S. economy’s strength has been underestimated, according to Chris Zaccarelli, chief investment officer for Independent Advisor Alliance. He suggests that markets worried about a growth slowdown should breathe a sigh of relief following the recent GDP number.

Despite the rollercoaster ride the financial world has been on this week, with warnings of a potential market crash and a surge in small-cap stocks, the U.S. economy has shown impressive strength.

Read Next:

  • Janet Yellen Rejects Economist Roubini’s And Trump-Era Official’s Claims Of ‘Manipulation’ In Treasuries: ‘We Have Never, Ever Discussed Anything Of The Sort’

Image Via Shutterstock

This story was generated using Benzinga Neuro and edited by Pooja Rajkumari

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsGlobalEconomicsGeneralAIfinancial serviceshealthcareinvestmentPooja RajkumariSingaporeStories That Matter
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...